151 related articles for article (PubMed ID: 9645799)
1. Mouse parvovirus infection potentiates allogeneic skin graft rejection and induces syngeneic graft rejection.
McKisic MD; Macy JD; Delano ML; Jacoby RO; Paturzo FX; Smith AL
Transplantation; 1998 Jun; 65(11):1436-46. PubMed ID: 9645799
[TBL] [Abstract][Full Text] [Related]
2. Mouse parvovirus infection potentiates rejection of tumor allografts and modulates T cell effector functions.
McKisic MD; Paturzo FX; Smith AL
Transplantation; 1996 Jan; 61(2):292-9. PubMed ID: 8600639
[TBL] [Abstract][Full Text] [Related]
3. Induction of hyperacute rejection of skin allografts by CD8+ lymphocytes.
Yoshimura R; Chargui J; Aitouche A; Veyron P; Touraine JL
Transplantation; 2000 Apr; 69(7):1452-7. PubMed ID: 10798770
[TBL] [Abstract][Full Text] [Related]
4. The expression patterns of CD44 and CD45RB on peripheral blood T lymphocytes in the rejection of allogeneic murine skin transplantation.
Yang J; Ahn C; Jung HK; Kim EK; Kim JY; Kim YS; Han JS; Kim S; Lee JS
Transpl Immunol; 2003; 11(2):197-206. PubMed ID: 12799204
[TBL] [Abstract][Full Text] [Related]
5. Induction of prolonged tolerance to third-party skin grafts following fully allogeneic bone marrow transplantation in mice.
Levite M; Reisner Y
Transplantation; 1993 Mar; 55(3):633-8. PubMed ID: 8456484
[TBL] [Abstract][Full Text] [Related]
6. Alloantigen-induced, T-cell-dependent production of nitric oxide by macrophages infiltrating skin allografts in mice.
Krulová M; Zajícová A; Fric J; Holán V
Transpl Int; 2002 Mar; 15(2-3):108-16. PubMed ID: 11935167
[TBL] [Abstract][Full Text] [Related]
7. Antisense deoxyoligonucleotides or antibodies to murine MD-1 inhibit rejection of allogeneic and xenogeneic skin grafts in C3H mice.
Hadidi S; Chen Z; Phillips J; Yu K; Gorczynski RM
Transplantation; 2002 Jun; 73(11):1771-9. PubMed ID: 12085000
[TBL] [Abstract][Full Text] [Related]
8. High-Risk Corneal Graft Rejection in the Setting of Previous Corneal Herpes Simplex Virus (HSV)-1 Infection.
Kuffova L; Knickelbein JE; Yu T; Medina C; Amescua G; Rowe AM; Hendricks RL; Forrester JV
Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1578-87. PubMed ID: 27050878
[TBL] [Abstract][Full Text] [Related]
9. Development of autoimmunity after skin graft rejection via an indirect alloresponse.
Valujskikh A; Fedoseyeva E; Benichou G; Heeger PS
Transplantation; 2002 Apr; 73(7):1130-7. PubMed ID: 11965045
[TBL] [Abstract][Full Text] [Related]
10. Gal mismatch alone causes skin graft rejection in mice.
Gock H; Murray-Segal L; Salvaris E; Cowan PJ; D'Apice AJ
Transplantation; 2002 Sep; 74(5):637-45. PubMed ID: 12352879
[TBL] [Abstract][Full Text] [Related]
11. Effector mechanisms in murine allograft rejection: comparison of skin and heart grafts in fully allogeneic and minor histocompatibility antigen-mismatched strain combinations.
Youssef AR; Otley C; Mathieson PW; Smith RM
Transpl Int; 2002 Jun; 15(6):302-9. PubMed ID: 12072901
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of antiskin allograft immunity induced by infusions with photoinactivated effector T lymphocytes (PET cells). Is in vivo cell transferrable?
Perez M; Lobo FM; Yamane Y; John L; Berger CL; Edelson RL
Ann N Y Acad Sci; 1991 Dec; 636():95-112. PubMed ID: 1793234
[TBL] [Abstract][Full Text] [Related]
13. Clonal analysis of the lymphoid cells mediating skin allograft rejection. Mediation of graft rejection in vivo by cloned Lyt-1+2- proliferative, noncytotoxic long-term cell lines.
Kim B; Rosenstein M; Weiland D; Eberlein TJ; Rosenberg SA
Transplantation; 1983 Nov; 36(5):525-32. PubMed ID: 6356516
[TBL] [Abstract][Full Text] [Related]
14. CD8+ effector cells responding to residual class I antigens, with help from CD4+ cells stimulated indirectly, cause rejection of "major histocompatibility complex-deficient" skin grafts.
Lee RS; Grusby MJ; Laufer TM; Colvin R; Glimcher LH; Auchincloss H
Transplantation; 1997 Apr; 63(8):1123-33. PubMed ID: 9133474
[TBL] [Abstract][Full Text] [Related]
15. Anti-CD4 abrogates rejection and reestablishes long-term tolerance to syngeneic newborn hearts grafted in mice chronically infected with Trypanosoma cruzi.
dos Santos RR; Rossi MA; Laus JL; Silva JS; Savino W; Mengel J
J Exp Med; 1992 Jan; 175(1):29-39. PubMed ID: 1730921
[TBL] [Abstract][Full Text] [Related]
16. Mixed allogeneic reconstitution (A+B----A) to induce donor-specific transplantation tolerance. Permanent acceptance of a simultaneous donor skin graft.
Ildstad ST; Wren SM; Oh E; Hronakes ML
Transplantation; 1991 Jun; 51(6):1262-7. PubMed ID: 1828637
[TBL] [Abstract][Full Text] [Related]
17. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
Yoshida R; Yoneda Y; Kuriyama M; Kubota T
J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
[TBL] [Abstract][Full Text] [Related]
18. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
[TBL] [Abstract][Full Text] [Related]
19. Survival of fetal skin grafts is prolonged on the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient mouse/skin allograft model.
Erdag G; Morgan JR
Transplantation; 2002 Feb; 73(4):519-28. PubMed ID: 11889422
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
